Photodynamic therapy (PDT) has been investigated extensively, both experimentally and
clinically, as an adjunctive treatment in the neuro-oncological field. It is based on the more …

… The activation sources ranged from various lamps, by argon-dye laser (Aurora M), KTP dye
laser and gold vapour lasers, whereas now diode lasers and LEDs are the current standard. …

… After 7 days, the concentration of m-THPC decreased to 76 … of m-THPC and 5-ALA in brain
tumours. Becauseof the different pharmacokinetic and toxicological profile, we recommend m-…

Radical tumor resection is the basis for the prolonged survival of patients suffering from
malignant brain tumors such as glioblastoma multiforme. We have carried out a phase‐II study …

… Chromaffin granules were incubated for 5 min at 37C in Tris/HCl (0.01 M)-buffered 0.3 M-sucrose
of various pH values. The results for the uptake of [3H]ATP (M) are mean values of …

PURPOSE: NovoTTF-100A is a portable device delivering low-intensity, intermediate
frequency electric fields via non-invasive, transducer arrays. Tumour Treatment Fields (TTF), a …

Since 1984, 58 patients bearing malignant brain tumors were treated 70 times with photodynamic
treatment (PDT). The patient population consisted of 11 primary glioblastoma WHO …

… The enzyme reaction was stopped by adding 100 µl 1 M phosphoric acid per well, and the
absorbance was measured at 450 nm. Samples were calculated from the standard curve in …

… l5mgfkg bw m-THPC. On day 4 intraoperative PDD and fluorescence guided tumor resection
(FGR… The second generation PS mTHPC proved to be superior regarding phototoxicity and …

Vascular endothelial growth factor (VEGF), a key regulatory protein in neoangiogenesis, is
strongly expressed in a variety of primary brain tumors, particularly malignant gliomas. In …